Updated Date: Thu, 23 Mar 2023 00:00:00 EDT

Therapy candidates chosen for lead projects targeting mast cell driven diseases

Therapy is a positive modulator and has demonstrated that it can improve learning and memory

Updated Date: Wed, 22 Mar 2023 00:00:00 EDT

Updated Date: Wed, 22 Mar 2023 00:00:00 EDT

Updated Date: Wed, 22 Mar 2023 00:00:00 EDT

Dr Beatriz Goulao receives more than £500,000 to make trials more patient-focused

Company’s candidate NP137 combined with mFOLFIRINOX will be researched during vital trials

Updated Date: Tue, 21 Mar 2023 00:00:00 EDT

MHRA designation involves entry into innovative licensing and access pathway